Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

Blood Adv (2025) 9 (21): 5571–5584.

https://doi.org/10.1182/bloodadvances.2025016778

Published: 2025

Includes: Supplemental data

Journal Articles

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Blood Adv (2025) 9 (21): 5460–5472.

https://doi.org/10.1182/bloodadvances.2025016141

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Blood Adv (2025) 9 (21): 5489–5500.

https://doi.org/10.1182/bloodadvances.2025016149

Published: 2025

Includes: Supplemental data

Journal Articles

Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

Blood Adv (2025) 9 (20): 5274–5282.

https://doi.org/10.1182/bloodadvances.2024015626

Published: 2025

Includes: Supplemental data

Journal Articles

Survival in Adults with High Risk TA-TMA - A Comparative Analysis of Narsoplimab Versus Supportive Care

Hiroyuki Matsui, Yasuyuki Arai, Junya Kanda, Tadakazu Kondo, Michelle L Schoettler, Mohamad Mohty, Miguel-Angel Perales, Rafael F. Duarte, Alessandro Rambaldi, Akifumi Takaori-Kondo

Blood Adv bloodadvances.2025017540.

https://doi.org/10.1182/bloodadvances.2025017540

Published: 2025

Journal Articles

Soluble Urokinase Plasminogen Activator Receptor and Acute Kidney Injury in Hematopoietic Cell Transplantation

Bhavna Bhasin-Chhabra, Tao Wang, John E. Levine, Shalini Shenoy, Miguel-Angel Perales, Asad Bashey, Hershel Raff, Wael Saber

Blood Adv bloodadvances.2025016655.

https://doi.org/10.1182/bloodadvances.2025016655

Published: 2025

Includes: Supplemental data

Journal Articles

Do not forget vaccinations in patients on Ig replacement

Sigrun Einarsdottir, Silvia Escribano Serrat, Marina Gomez-Llobell, Malin L Hultcrantz, Mini Kamboj, Miguel-Angel Perales, Roni Shouval, Zainab Shahid, Per Ljungman

Blood Adv bloodadvances.2025018127.

https://doi.org/10.1182/bloodadvances.2025018127

Published: 2025

Journal Articles

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

Andrea P. Chung, Jason T. Shafrin, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard C. Alsfeld, Sanjana Muthukrishnan, Anik R. Patel, Gunjan L. Shah, Richard T. Maziarz

Blood Adv (2025) 9 (18): 4727–4735.

https://doi.org/10.1182/bloodadvances.2024015634

Published: 2025

Includes: Supplemental data

Journal Articles

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Blood Adv bloodadvances.2024015599.

https://doi.org/10.1182/bloodadvances.2024015599

Published: 2025

Includes: Supplemental data

Journal Articles

NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell Lymphoma

Sairah Ahmed, John F. DiPersio, James H Essell, Catherine Diefenbach, Miguel-Angel Perales, Cristina Castilla-Llorente, Saurabh Dahiya, Yi Liu, PhD, Heng Xu, Christie Fanton, Sohail Chaudhry, Zachary Lee, A Mario Q. Marcondes, Mary Tagliaferri, Jonathan Zalevsky, David B. Miklos, Cameron J. Turtle, Joseph P. McGuirk

Blood Adv bloodadvances.2025016423.

https://doi.org/10.1182/bloodadvances.2025016423

Published: 2025

Includes: Supplemental data

Journal Articles

Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

Miguel-Angel Perales, Marcie Riches, Naya He, Michael J. Martens, Roy F. Chemaly, Christopher E. Dandoy, Joshua A. Hill, Miguel Angel Diaz, Shahrukh Hashmi, Susan Prockop, Hillard M. Lazarus, Amer M. Beitinjaneh, Gerhard C. Hildebrandt, Jeffery J. Auletta, Paul Szabolcs

Blood Adv (2025) 9 (14): 3502–3517.

https://doi.org/10.1182/bloodadvances.2024015288

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

Blood Adv (2025) 9 (14): 3495–3501.

https://doi.org/10.1182/bloodadvances.2025015964

Published: 2025

Includes: Supplemental data

Journal Articles

Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

Blood Adv (2025) 9 (10): 2570–2584.

https://doi.org/10.1182/bloodadvances.2024014177

Published: 2025

Journal Articles

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

Blood Adv (2025) 9 (7): 1644–1657.

https://doi.org/10.1182/bloodadvances.2024015157

Published: 2025

Includes: Supplemental data

Journal Articles

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

Peter A. Riedell, Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T. Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J. Schuster, Andy I. Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P. McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter

Blood Adv (2025) 9 (5): 1232–1241.

https://doi.org/10.1182/bloodadvances.2024014164

Published: 2025

Includes: Supplemental data

Journal Articles

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Blood Adv (2024) 9 (1): 151–161.

https://doi.org/10.1182/bloodadvances.2024014555

Published: 2024

Includes: Supplemental data

Journal Articles

Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity

Blood Adv (2024) 8 (21): 5603–5611.

https://doi.org/10.1182/bloodadvances.2024013636

Published: 2024

Includes: Supplemental data

Journal Articles

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Nausheen Ahmed, William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanova, Loretta J. Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Michael R. Bishop, Joseph P. McGuirk, Peter A. Riedell

Blood Adv (2024) 8 (20): 5346–5354.

https://doi.org/10.1182/bloodadvances.2023012549

Published: 2024

Includes: Supplemental data

Journal Articles

CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas

Blood Adv (2024) 8 (19): 5192–5199.

https://doi.org/10.1182/bloodadvances.2024013393

Published: 2024

Includes: Supplemental data

Journal Articles

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Tania Jain, Noel Estrada-Merly, M. Queralt Salas, Soyoung Kim, Jakob DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher Bredeson, Zachariah DeFilipp, Bhagirathbhai Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita P. Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R. Grunwald, Nada Hamad, Betty K. Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer Jamy, Mark Juckett, Mohamed A. Kharfan-Dabaja, Maxwell M. Krem, Deepesh P. Lad, Jane Liesveld, Monzr M. Al Malki, Adriana K. Malone, Hemant S. Murthy, Guillermo Ortí, Sagar S. Patel, Attaphol Pawarode, Miguel-Angel Perales, Marjolein van der Poel, Olle Ringden, David A. Rizzieri, Alicia Rovó, Bipin N. Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, John R. Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J. Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber, Vikas Gupta

Blood Adv (2024) 8 (16): 4281–4293.

https://doi.org/10.1182/bloodadvances.2024013451

Published: 2024

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

Survival in Adults with High Risk TA-TMA - A Comparative Analysis of Narsoplimab Versus Supportive Care

Soluble Urokinase Plasminogen Activator Receptor and Acute Kidney Injury in Hematopoietic Cell Transplantation

Do not forget vaccinations in patients on Ig replacement

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell Lymphoma

Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only